Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conference
AUSTIN, Texas, Feb. 05, 2024 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate […]
TSX News -
illumin Announces Personnel Changes
TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) — illumin Holdings Inc. (TSX:ILLM) (“illumin” or the “Company”) announced that effective today, Mr. […]
Kforce Reports Fourth Quarter 2023 Revenue of $363.4 Million and Earnings Per Share of $0.82; Full Year 2023 EPS of $3.13 Per Share, as Reported, and $3.49 Per Share, as Adjusted; Board of Directors Approves 5.5% Increase in Dividend and Increases Share Buyback Authorization to $100 Million
TAMPA, Fla., Feb. 05, 2024 (GLOBE NEWSWIRE) — Kforce Inc. (Nasdaq: KFRC), a solutions firm that specializes in technology and […]
Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
WALTHAM, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect […]
Alico, Inc. to Announce First Quarter 2024 Financial Results on Wednesday, February 7, 2024
FORT MYERS, Fla., Feb. 05, 2024 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that […]
Symbotic Reports First Quarter Fiscal Year 2024 Results
WILMINGTON, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) — Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the […]
TSX News -
Coveo Reports Third Quarter Fiscal 2024 Financial Results
SaaS Subscription Revenue(1)of $29.9 million, ahead of previous guidanceOperating loss reduced by 40% year-over-year; Adjusted Operating Loss(2)well ahead of guidanceContinued […]
TSX News -
James Mannebach is appointed as CEO of Velan
MONTREAL, Feb. 05, 2024 (GLOBE NEWSWIRE) — Velan Inc. (“Velan”) (TSX: VLN) today announces that its board of directors has […]
Immix Biopharma Announces Proposed Public Offering of Common Stock
LOS ANGELES, Feb. 05, 2024 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (Nasdaq: IMMX) (the “Company”), a clinical-stage biopharmaceutical company trailblazing […]
Premier Diversified Holdings Inc. Announces Cease Trade Order and Provides Update on the Proposed Acquisition of AJA Health and Wellness Ltd., Assured Diagnosis Inc., and AJA Therapeutics Inc.
Not for dissemination in the United States of America VANCOUVER, British Columbia, Feb. 05, 2024 (GLOBE NEWSWIRE) — Premier Diversified […]
